دانلود کتاب سرطان ریه: رویکرد مبتنی بر شواهد به مدیریت چند رشته ای
Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management, 1ed

Care of the lung cancer patient―screening, diagnosis, and treatment―has undergone recent dramatic changes due to technologic and research-driven advances. Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management covers every aspect of this fast-changing field, including new screening guidelines, new practice standards, and new treatment advances that have led to higher survival rates. This practical, clinically oriented resource provides thorough, evidence-based coverage from experts in the field, including the increasingly important precision medicine approach in lung cancer planning and management.

• Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more.
• Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies.
• Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and  PET/CT and CT imaging for diagnosis and treatment planning.
• Features “Top 5 Clinical Pearls” at the beginning of each chapter.
• Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective.

Contents

۱. Lung cancer screening and prevention
۲. Lung cancer: Diagnostic techniques
۳. Histology and molecular testing
۴. Surgical considerations in lung cancer treatment
۵. Surgically resectable disease
۶. Oligometastatic disease
۷. Locally advanced non–small cell lung cancer
۸. First-line therapy
۹. Second-line therapy in advanced non–small cell lung cancer
۱۰. Epidermal growth factor receptor–mutated non–small cell lung cancer: a clinical approach
۱۱. Diagnosis and treatment of anaplastic lymphoma kinase (ALK) rearranged non−small cell lung cancer
۱۲. Other molecular cohorts including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
۱۳. Immunotherapy
۱۴. Small cell lung cancer